Quarterly report [Sections 13 or 15(d)]

Balance Sheet Components

v3.25.1
Balance Sheet Components
3 Months Ended
Mar. 31, 2025
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components

4. Balance sheet components

Accounts receivable and allowance for bad debts, returns, and adjustments

Net accounts receivable (gross accounts receivable, net of allowances) balance concentrations by major category as of March 31, 2025 and December 31, 2024 were as follows:

 

 

March 31,

 

 

December 31,

 

Net accounts receivable

 

2025

 

 

2024

 

Rental (1)

 

$

6,269

 

 

$

4,863

 

Business-to-business and other receivables

 

 

30,354

 

 

 

24,700

 

Total net accounts receivable

 

$

36,623

 

 

$

29,563

 

 

(1) Rental includes Medicare, Medicaid/other government, private insurance, and patient pay.

The following table sets forth the accounts receivable allowances as of March 31, 2025 and December 31, 2024:

 

 

March 31,

 

 

December 31,

 

Allowances - accounts receivable

 

2025

 

 

2024

 

Doubtful accounts

 

$

91

 

 

$

458

 

Sales returns

 

 

484

 

 

 

413

 

Total allowances - accounts receivable

 

$

575

 

 

$

871

 

Concentration of customers and vendors

The Company primarily sells its products to traditional home medical equipment providers, distributors, and resellers in the United States and in foreign countries on a credit basis. The Company also sells its products direct-to-consumers primarily on a prepayment basis. One single customer represented more than 10% of the Company's total revenue for the three months ended March 31, 2025. One customer represented more than 10% of the Company’s net accounts receivable balance with a net accounts receivable balance of $4,302 as of March 31, 2025 and $3,288 as of December 31, 2024.

The Company also rents products directly to consumers for insurance reimbursement, which resulted in a customer concentration relating to Medicare’s service reimbursement programs. Medicare’s service reimbursement programs accounted for 55.0% and 58.4% of rental revenue in the three months ended March 31, 2025 and 2024, respectively, and accounted for 9.2% and 11.2% of total revenue for the three months ended March 31, 2025 and 2024, respectively. Accounts receivable balances relating to Medicare’s service reimbursement programs (including held and unbilled, net of allowances) amounted to $1,352, or 3.7%, of total net accounts receivable as of March 31, 2025 compared to $1,107, or 4.8%, of total net accounts receivable as of December 31, 2024.

The Company currently purchases raw materials from a limited number of vendors, which resulted in a concentration of three major vendors. The three major vendors supply the Company with raw materials used to manufacture the Company’s products. For the three months ended March 31, 2025, the Company’s three major vendors accounted for 17.9%, 10.8%, and 10.6%, respectively, of total raw material purchases. For the three months ended March 31, 2024, the Company’s three major vendors accounted for 24.6%, 17.2%, and 10.0%, respectively, of total raw material purchases.

A portion of revenue is earned from sales outside the United States. Approximately 78.9% and 79.9% of the non-U.S. revenue for the three months ended March 31, 2025 and 2024, respectively, were invoiced in Euros. A breakdown of the Company’s revenue from U.S. and non-U.S. sources for the three months ended March 31, 2025 and 2024, respectively, is as follows:

 

 

Three months ended
March 31,

 

 

 

2025

 

 

2024

 

U.S. revenue

 

$

50,295

 

 

$

51,990

 

Non-U.S. revenue

 

 

31,985

 

 

 

26,035

 

Total revenue

 

$

82,280

 

 

$

78,025

 

Inventories

Inventories are stated at the lower of cost and net realizable value, using the first-in, first-out, or FIFO, method. The Company records adjustments to inventory for potentially excess, obsolete, slow-moving or impaired items, and losses on firm purchase commitments as a component of cost of sales in the consolidated statements of comprehensive loss. The Company recorded noncurrent inventory related to inventories that are expected to be realized or consumed after one year of $679 and $1,291 as of March 31, 2025 and December 31, 2024, respectively. Noncurrent inventories are primarily related to raw materials purchased in bulk to support long-term expected repairs to reduce costs and are classified in other assets. During the three months ended March 31, 2025 and 2024, $149 and $331, respectively, of inventory was transferred to rental equipment and was considered a noncash transaction in the production and purchase of rental equipment on the consolidated statements of cash flows. Inventories that are considered current consist of the following:

 

 

March 31,

 

 

December 31,

 

 

 

2025

 

 

2024

 

Raw materials and work-in-progress

 

$

19,401

 

 

$

19,224

 

Finished goods

 

 

8,882

 

 

 

7,633

 

Less: reserves

 

 

(2,010

)

 

 

(2,045

)

Inventories, net

 

$

26,273

 

 

$

24,812

 

Property and equipment

Expenditures for additions, improvements and replacements are capitalized and depreciated to a salvage value of $0. Repair and maintenance costs on rental equipment are included in cost of rental revenue on the consolidated statements of comprehensive loss. Repair and maintenance expense, which includes labor, parts, and freight, for rental equipment was $1,838 and $1,759 for the three months ended March 31, 2025 and 2024, respectively.

Depreciation and amortization expense related to rental equipment and other property and equipment are summarized below for the three months ended March 31, 2025 and 2024, respectively.

 

 

Three months ended
March 31,

 

 

 

2025

 

 

2024

 

Rental equipment

 

$

3,034

 

 

$

3,179

 

Other property and equipment

 

 

1,016

 

 

 

1,154

 

Total depreciation and amortization

 

$

4,050

 

 

$

4,333

 

 

Property and equipment and rental equipment with associated accumulated depreciation is summarized below as of March 31, 2025 and December 31, 2024, respectively.

 

 

March 31,

 

 

December 31,

 

Property and equipment

 

2025

 

 

2024

 

Rental equipment, net of allowances of $3,805 and $3,744, respectively

 

$

62,019

 

 

$

64,012

 

Other property and equipment

 

 

24,837

 

 

 

25,123

 

Property and equipment

 

 

86,856

 

 

 

89,135

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

Rental equipment

 

 

32,400

 

 

 

32,294

 

Other property and equipment

 

 

13,357

 

 

 

12,441

 

Accumulated depreciation

 

 

45,757

 

 

 

44,735

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

 

 

 

 

Rental equipment, net of allowances of $3,805 and $3,744, respectively

 

 

29,619

 

 

 

31,718

 

Other property and equipment

 

 

11,480

 

 

 

12,682

 

Property and equipment, net

 

$

41,099

 

 

$

44,400

 

Long-lived assets

The Company accounts for the impairment and disposition of long-lived assets in accordance with Accounting Standards Codification, or ASC, 360 Property, Plant, and Equipment. Long-lived assets are reviewed for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. No impairments were recorded for the three months ended March 31, 2025 and 2024.

Goodwill and other identifiable intangible assets

Goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2025 were as follows:

 

Balance as of December 31, 2024 (1)

 

$

9,465

 

Translation adjustment

 

 

395

 

Balance as of March 31, 2025 (1)

 

$

9,860

 

(1) Includes $32,894 of accumulated impairment losses as of March 31, 2025 and December 31, 2024.

Intangible assets

Intangible assets as of March 31, 2025 and December 31, 2024 consisted of the following:

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

estimated

 

Gross

 

 

 

 

 

 

 

 

 

useful lives

 

carrying

 

 

Accumulated

 

 

 

 

March 31, 2025

 

(in years)

 

amount

 

 

amortization

 

 

Net amount

 

Developed technology

 

10

 

$

32,651

 

 

$

5,034

 

 

$

27,617

 

Licenses

 

10

 

 

159

 

 

 

159

 

 

 

 

Patents and websites

 

5

 

 

3,776

 

 

 

3,765

 

 

 

11

 

Customer relationships

 

4-10

 

 

2,915

 

 

 

1,547

 

 

 

1,368

 

Trade name

 

4

 

 

202

 

 

 

78

 

 

 

124

 

Commercials

 

3

 

 

494

 

 

 

323

 

 

 

171

 

Internally developed software

 

3

 

 

3,175

 

 

 

859

 

 

 

2,316

 

Total

 

 

 

$

43,372

 

 

$

11,765

 

 

$

31,607

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

estimated

 

Gross

 

 

 

 

 

 

 

 

 

useful lives

 

carrying

 

 

Accumulated

 

 

 

 

December 31, 2024

 

(in years)

 

amount

 

 

amortization

 

 

Net amount

 

Developed technology

 

10

 

$

31,342

 

 

$

4,048

 

 

$

27,294

 

Licenses

 

10

 

 

159

 

 

 

159

 

 

 

 

Patents and websites

 

5

 

 

3,776

 

 

 

3,752

 

 

 

24

 

Customer relationships

 

4-10

 

 

2,799

 

 

 

1,447

 

 

 

1,352

 

Trade name

 

4

 

 

194

 

 

 

63

 

 

 

131

 

Commercials

 

3

 

 

494

 

 

 

282

 

 

 

212

 

Internally developed software

 

3

 

 

2,090

 

 

 

610

 

 

 

1,480

 

Total

 

 

 

$

40,854

 

 

$

10,361

 

 

$

30,493

 

Annual estimated amortization expense for each of the succeeding fiscal years is as follows:

 

 

March 31,

 

 

 

2025

 

Remaining 9 months of 2025

 

$

3,532

 

2026

 

 

4,588

 

2027

 

 

3,911

 

2028

 

 

3,442

 

2029

 

 

3,427

 

2030

 

 

3,427

 

Thereafter

 

 

9,280

 

Total

 

$

31,607

 

Current liabilities

Accounts payable and accrued expenses as of March 31, 2025 and December 31, 2024 consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

 

 

2025

 

 

2024

 

Accounts payable

 

$

23,257

 

 

$

16,616

 

Accrued inventory (in-transit and unvouchered receipts) and trade payables

 

 

7,531

 

 

 

6,917

 

Accrued loss on purchase commitments

 

 

701

 

 

 

672

 

Forward contract payable

 

 

1,888

 

 

 

 

Other accrued expenses

 

 

2,548

 

 

 

2,948

 

Total accounts payable and accrued expenses

 

$

35,925

 

 

$

27,153

 

 

Accrued payroll as of March 31, 2025 and December 31, 2024 consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

 

 

2025

 

 

2024

 

Accrued bonuses

 

$

1,968

 

 

$

6,370

 

Accrued wages and other payroll related items

 

 

3,469

 

 

 

5,570

 

Accrued vacation

 

 

3,981

 

 

 

3,456

 

Accrued severance

 

 

926

 

 

 

1,429

 

Accrued employee stock purchase plan deductions

 

 

169

 

 

 

364

 

Total accrued payroll

 

$

10,513

 

 

$

17,189